https://www.city-journal.org/article/hhs-pediatric-gender-medicine-review-wpath
One of President Trump’s first executive orders was the provocatively titled “Protecting Children from Chemical and Surgical Mutilation.” The order directed federally funded insurance programs to end coverage of pediatric sex-trait modification and barred hospitals receiving federal funds from performing such interventions. It also instructed the Department of Health and Human Services (HHS) to conduct a review of the evidence and ethical considerations surrounding pediatric gender medicine.
That review, “Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices,” was released earlier this month. It is already being described as America’s Cass Review, the landmark gender-medicine review published last year in the United Kingdom.
This report is long overdue. While European health authorities in countries like Sweden, Finland, Norway, and the U.K. have moved away from the “gender-affirming” model and toward cautious psychological support for gender-dysphoric children, American institutions have only become more entrenched in the model despite growing evidence of the harm and weak benefits.
The HHS report breaks this trend, providing a comprehensive and sober reevaluation of the science, ethics, and clinical practices in pediatric gender medicine. At more than 400 pages, with chapters on history, terminology, evidence, ethics, and clinical realities, it is the most thorough and ambitious document of its kind in the United States.
The report’s central findings are clear and direct: gender-affirming interventions such as puberty blockers, cross-sex hormones, and surgeries are supported only by low- or very low-quality evidence, while the potential for irreversible harm is substantial. Risks include sterility, sexual dysfunction, impaired bone-density and brain development, psychiatric comorbidities, and surgical complications. The report rejects claims that gender transition reduces suicidality, finding no high-quality evidence to support this oft-repeated assertion. In line with international reviews, it concludes that psychotherapy should be the first-line treatment for youth with gender dysphoria.